OMNICYTE

Welcome to the Brand page for “OMNICYTE”, which is offered here for Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical products for the prevention and treatment of cancer;omni cyte; omni sight;active chemical ingredients for use in the manufacture of anti-cancer drugs; diagnostic preparations for clinical or medical laboratory use; laboratory chemicals, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use;.

Its status is currently believed to be active. Its class is unavailable. “OMNICYTE” is believed to be currently owned by “Healthcare Capital Partners, LLC”.